Scientific Publications


Real-world big-data: Strengths and weaknesses of ASCO's CancerLinQ Discovery® multiple myeloma dataset

American Journal of Hematology
DeStefano CB

Evaluation of cost-effectiveness of adjuvant osimertinib in patients with resected EGFR mutation-positive non-small cell lung cancer

PharmacoEconomics - Open
Verhoek A et al

Challenges to using big data in cancer

Cancer Research
Sweeney SM et al

Case studies for overcoming challenges in using big data in cancer

Cancer Research
Sweeney SM et al

Incidence of SARS-CoV-2 and subsequent mortality in a multi-site cohort of patients with cancer in the CancerLinQ Discovery database

JCO Oncology Practice
Ray et al

Retrospective analysis of real‐world management of EGFR‐mutated advanced NSCLC, after first‐line EGFR‐TKI treatment: US treatment patterns, attrition,…

Drugs Real World Outcomes
Nieva J et al

Reaching beyond maximum grade: Progress and future directions for modernising the assessment and reporting of adverse events in haematological maligna…

The Lancet Haematology
Thanarajasingam G et al.

Cancer registry data linkage of electronic health record data from ASCO’s CancerLinQ: Evaluation of advantages, limitations, and lessons learned

JCO Clinical Cancer Informatics
Charlton et al.

Real-world clinical outcomes of patients with BRCA-mutated, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: a Cance…

Breast Cancer Research and Treatment
Miller et al.


Pitfalls with analyses of real-world data: A look at ASCO’s CancerLinQ Discovery Multiple Myeloma dataset

ASCO Annual Meeting 2023
Shou K J et al

A real-world study of US patients with metastatic ovarian, fallopian tube, and peritoneal cancer (mOFPC) using integrated electronic health records (E…

ASCO Annual Meeting 2023
Avinash P B et al

The RESECT study: Factors associated with overall survival (OS) and relapse-free survival (RFS) among patients with stages I–III resected NSCLC withou…

ASCO Annual Meeting 2023
Gray J E et al

Real-world response endpoints in patients with mNSCLC treated with chemotherapy across real-world datasets

ASCO Annual Meeting 2023
McKelvey B A et al

Electronic health record (EHR) and genomics-based machine learning (ML) to predict therapeutic effectiveness among patients with hormone-receptor posi…

ASCO Annual Meeting 2023
Hathi D et al

Association between severe adverse event management and overall survival in patients treated with immune checkpoint inhibitor with advanced non–small-…

ASCO Annual Meeting 2023
Naidoo J et al

Development of natural language processing (NLP) models for extracting key features from unstructured notes to create real-world data (RWD) assets for…

ASCO Annual Meeting 2023
Agrawal S et al

Treatment patterns and outcomes among locally advanced cervical cancer patients receiving concurrent chemoradiotherapy

ASCO Annual Meeting 2023
Coutinho F et al

Enhancement in line of therapy (LoT) derivation from real-world data (RWD) from electronic health records (EHR) via integration of medical claims data

ASCO Annual Meeting 2023
Agrawal S et al